Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2188765884;65885;65886 chr2:178583144;178583143;178583142chr2:179447871;179447870;179447869
N2AB2024660961;60962;60963 chr2:178583144;178583143;178583142chr2:179447871;179447870;179447869
N2A1931958180;58181;58182 chr2:178583144;178583143;178583142chr2:179447871;179447870;179447869
N2B1282238689;38690;38691 chr2:178583144;178583143;178583142chr2:179447871;179447870;179447869
Novex-11294739064;39065;39066 chr2:178583144;178583143;178583142chr2:179447871;179447870;179447869
Novex-21301439265;39266;39267 chr2:178583144;178583143;178583142chr2:179447871;179447870;179447869
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTT
  • RefSeq wild type template codon: CAA
  • Domain: Ig-125
  • Domain position: 22
  • Structural Position: 35
  • Q(SASA): 0.1563
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/I None None 0.767 N 0.25 0.244 0.556581311739 gnomAD-4.0.0 3.18865E-06 None None None None N None 0 0 None 0 0 None 0 0 5.72659E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.8123 likely_pathogenic 0.7654 pathogenic -1.542 Destabilizing 0.998 D 0.594 neutral N 0.486546181 None None N
V/C 0.9582 likely_pathogenic 0.9455 pathogenic -0.717 Destabilizing 1.0 D 0.817 deleterious None None None None N
V/D 0.9972 likely_pathogenic 0.9963 pathogenic -1.406 Destabilizing 1.0 D 0.851 deleterious D 0.60364195 None None N
V/E 0.9914 likely_pathogenic 0.9898 pathogenic -1.406 Destabilizing 1.0 D 0.837 deleterious None None None None N
V/F 0.7385 likely_pathogenic 0.6541 pathogenic -1.259 Destabilizing 0.999 D 0.829 deleterious D 0.533185338 None None N
V/G 0.942 likely_pathogenic 0.9235 pathogenic -1.865 Destabilizing 1.0 D 0.85 deleterious D 0.571371064 None None N
V/H 0.9957 likely_pathogenic 0.9941 pathogenic -1.484 Destabilizing 1.0 D 0.868 deleterious None None None None N
V/I 0.0978 likely_benign 0.0937 benign -0.746 Destabilizing 0.767 D 0.25 neutral N 0.505129155 None None N
V/K 0.9933 likely_pathogenic 0.9917 pathogenic -1.197 Destabilizing 1.0 D 0.838 deleterious None None None None N
V/L 0.6045 likely_pathogenic 0.5321 ambiguous -0.746 Destabilizing 0.981 D 0.61 neutral D 0.57612662 None None N
V/M 0.6435 likely_pathogenic 0.5747 pathogenic -0.419 Destabilizing 1.0 D 0.779 deleterious None None None None N
V/N 0.9903 likely_pathogenic 0.9869 pathogenic -0.884 Destabilizing 1.0 D 0.877 deleterious None None None None N
V/P 0.9882 likely_pathogenic 0.9861 pathogenic -0.978 Destabilizing 1.0 D 0.84 deleterious None None None None N
V/Q 0.9889 likely_pathogenic 0.9862 pathogenic -1.056 Destabilizing 1.0 D 0.857 deleterious None None None None N
V/R 0.9852 likely_pathogenic 0.9822 pathogenic -0.692 Destabilizing 1.0 D 0.869 deleterious None None None None N
V/S 0.9519 likely_pathogenic 0.9352 pathogenic -1.362 Destabilizing 1.0 D 0.836 deleterious None None None None N
V/T 0.8879 likely_pathogenic 0.8608 pathogenic -1.257 Destabilizing 0.998 D 0.677 prob.neutral None None None None N
V/W 0.995 likely_pathogenic 0.9925 pathogenic -1.482 Destabilizing 1.0 D 0.851 deleterious None None None None N
V/Y 0.9711 likely_pathogenic 0.9593 pathogenic -1.195 Destabilizing 1.0 D 0.826 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.